- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Hong Kong Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
2
0 new
High return on equity, past performance and sound balance sheet.
2 companies
Consun Pharmaceutical Group
Market Cap: HK$9.7b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$11.62
7D
5.1%
1Y
102.1%
Uni-Bio Science Group
Market Cap: HK$537.4m
An investment holding company, researches and develops, manufactures, and sells biological and chemical pharmaceutical products to treat human diseases in the People’s Republic of China.
690
HK$0.09
7D
9.8%
1Y
45.2%